- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04910763
Prediabetes, Exercise, and Appetite Regulation (PEAR)
October 13, 2022 updated by: Tanya Halliday, University of Utah
Alterations to Appetite Regulation Indices in Adults With Prediabetes Following Short-Term Aerobic vs. Resistance Exercise Training
The purpose of the study is to learn about how type of exercise influences measures of appetite regulation.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
The primary objective of this study is to understand the relationship between exercise modality and appetite regulation in a population with pre-diabetes.
The study includes a screening visit to ensure eligibility of participants, baseline assessments, a resistance exercise intervention, and post intervention measurements.
The variables of interest include, but are not limited to, hormonal responses to exercise training pertaining to appetite, food cravings, appetite ratings.
activity levels, body composition, and ten repetition-max strength.
The aim of this study is to better understand the mechanisms involved in the correlation or causation of any improvements in fitness and appetite regulation in a cohort with pre-diabetes.
Study Type
Interventional
Enrollment (Actual)
23
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Utah
-
Salt Lake City, Utah, United States, 84112
- University of Utah
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 18-50 years of age
- BMI between 27-40 kg/m²
- Hemoglobin A1c level between 5.7% and 6.4%
- Physical Activity (less than 150 min/week moderate-intensity Physical Activity, no more than 1 session/week of resistance exercise)
Exclusion Criteria:
- Unstable Cardiovascular Disease
- Uncontrolled hypertension
- Severe hypertriglyceridemia
- History of or active liver disease
- Uncontrolled thyroid disease
- Active cancer diagnosis
- Smoking
- Engaged in exercise or diet program
- History of bariatric surgery
- GI malabsorptive disorders
- Significant diet intolerances
- History of major psychiatric disorder
- presence of alcohol or substance abuse;
- medications affecting weight,
- EI or EE in past 6 months;
- women currently pregnant, lactating, less than 6 months post-partum, or postmenopausal.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Resistance Exercise
Resistance exercise will be training all major muscle groups 2x/week (2 days upper body, 2 days lower body) at 40-50% 1 repetition max (RM; estimated from 10 RM baseline testing) for 3 sets of 10-12 reps.
This equals 4x/week for the 3 week intervention period.
|
Increasing strength and fitness and thereby influencing hormones and perceptions involved in appetite regulation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in Appetite Rating
Time Frame: Baseline: Pre-Meal , 30 minutes, 60 minutes, 90 minutes, and 120 minutes post meal / Post-intervention(Week 4) :Pre-Meal, 30 minutes, 60 minutes, 90 minutes ,and 120 minutes post meal
|
Hunger/Satiety before/after consumption of a meal
|
Baseline: Pre-Meal , 30 minutes, 60 minutes, 90 minutes, and 120 minutes post meal / Post-intervention(Week 4) :Pre-Meal, 30 minutes, 60 minutes, 90 minutes ,and 120 minutes post meal
|
Changes in Hormonal Response to Feeding
Time Frame: Baseline: Pre-Meal , 30 minutes, 60 minutes, 90 minutes, and 120 minutes post meal / Post-intervention(Week 4) :Pre-Meal, 30 minutes, 60 minutes, 90 minutes ,and 120 minutes post meal
|
Assessment of Ghrelin levels analyzed in blood samples before/after feeding.
|
Baseline: Pre-Meal , 30 minutes, 60 minutes, 90 minutes, and 120 minutes post meal / Post-intervention(Week 4) :Pre-Meal, 30 minutes, 60 minutes, 90 minutes ,and 120 minutes post meal
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in Body Composition
Time Frame: Baseline and Post-intervention(Week 4)
|
Measured via BodPod
|
Baseline and Post-intervention(Week 4)
|
Changes in Maximal Strength
Time Frame: Baseline and Post-intervention(Week 4)
|
Measurement via 10 repetition-max testing.
|
Baseline and Post-intervention(Week 4)
|
Changes in Physical Activity Levels
Time Frame: Baseline and Post-intervention(Week 4)
|
Measured via ActivPal Monitor
|
Baseline and Post-intervention(Week 4)
|
Changes in Food-Related Behaviors
Time Frame: Baseline and Post-intervention(Week 4)
|
Evaluated via the Food Craving Inventory
|
Baseline and Post-intervention(Week 4)
|
Changes in Food-Related Behaviors
Time Frame: Baseline and Post-intervention(Week 4)
|
Evaluated via Three-Factor Eating Questionnaire
|
Baseline and Post-intervention(Week 4)
|
Changes in Food-Related Behaviors
Time Frame: Baseline and Post-intervention(Week 4)
|
Evaluated via the Weight Efficacy Lifestyle Questionnaire
|
Baseline and Post-intervention(Week 4)
|
Change in Ad libitum Energy Intake - In lab
Time Frame: Baseline and Post-intervention(Week 4)
|
In lab ad libitum buffet lunch (via weigh and measure methodology)
|
Baseline and Post-intervention(Week 4)
|
Changes in Ad libitum Energy Intake - Free Living
Time Frame: Baseline and Post-intervention(Week 4)
|
3 days of free-living ad libitum energy intake (via self-report)
|
Baseline and Post-intervention(Week 4)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Tanya M Halliday, PhD, RD, University of Utah
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 12, 2019
Primary Completion (Actual)
September 3, 2021
Study Completion (Actual)
September 28, 2022
Study Registration Dates
First Submitted
April 19, 2021
First Submitted That Met QC Criteria
June 1, 2021
First Posted (Actual)
June 2, 2021
Study Record Updates
Last Update Posted (Actual)
October 17, 2022
Last Update Submitted That Met QC Criteria
October 13, 2022
Last Verified
October 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 000116248
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on PreDiabetes
-
Mayo ClinicNot yet recruiting
-
Aga Khan UniversityLinnaeus University; Kenyatta UniversityRecruiting
-
Philip KernNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting
-
Chonbuk National University HospitalCompletedPreDiabetes
-
National Yang Ming UniversityRecruiting
-
Albert Einstein College of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Clinical Nutrition Research Centre, SingaporeSingapore Institute for Clinical SciencesCompleted
-
Northwestern UniversityAllianceChicago; Erie Family Health CentersCompleted
-
Ohio UniversityTouro University, CaliforniaCompletedPreDiabetes
-
Chinese Association of Geriatric ResearchCompleted
Clinical Trials on Resistance Exercise
-
Princess Nourah Bint Abdulrahman UniversityKırıkkale UniversityCompleted
-
Universidade Federal de PernambucoUnknownChikungunya FeverBrazil
-
University of PittsburghNational Heart, Lung, and Blood Institute (NHLBI)TerminatedChildhood ObesityUnited States
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension | Healthy
-
Iowa State UniversityCompletedCardiovascular Risk Factor
-
University of AlbertaDexCom, Inc.CompletedType 1 DiabetesCanada
-
Mekelle UniversityCompleted
-
University of AlbertaCompletedType 1 DiabetesCanada
-
University of BirminghamMaastricht UniversityRecruitingSarcopenia | Resistance Exercise | Dietary ProteinUnited Kingdom
-
University of KansasWithdrawnAnterior Cruciate Ligament Injuries | Anterior Cruciate Ligament Rupture | Anterior Cruciate Ligament Tear | Atrophy, MuscularUnited States